1Huizinga EG , Tsuji S, Romijn RA, et al. Structures of glycoprotein Ⅰ bα and its complex with von Willebrand factor A1-domain[J]. Science, 2002, 297(5584): 1176 -1179.
2Uff S, Clemetson JM, Harrison T, et al. Crystal structure of the platelet glycoprotein Ⅰ bα N-terminal domain reveals an unmasking mechanism for receptor activation[J]. J Biol Chem, 2002,277(38) :35657 - 35663.
3Shen Y, Romo GM, Dong JF, et al. Requirement of leucine-rich repeats of glycoprotein (GP) Ⅰ bα for sheardependent and static binding of von Willebrand factor to the platelet membrane GP Ⅰ b-Ⅸ-Ⅴ complex [J]. Blood,2000,95(3):903-910.
4Arya M, Lopez JA, Romo GM, et al. Measurement of the binding forces between von Willebrand factor and variants of platelet glycoprotein Ⅰ bα using optical tweezers[J]. Lasers Surg Med, 2002,30(4) :306 - 312.
5Cauwenberghs N, Vanhoorelbeke K, Vauterin S, et al.Epitope mapping of inhibitory antibodies against platelet glycoprotein Ⅰ bα reveals interaction between the leucine-rich repeat N-terminal and C-terminal flanking domains of glycoprotein Ⅰbα[J]. Blood, 2001,98(3):652-660.
6Ulrichts H, Vanhoorelbeke K, Cauwenberghs S, et al. von Willebrand factor but not alpha-thrombin binding to platelet glycoprotein Ⅰ bα is influenced by the HPA-2 polymorphism [J]. Arterioscler Thromb Vasc Biol,2003,23(7): 1302 -1307.
7Shimizu A, Matsushita T, Kondo T, et al. Identification of the amino acid residues of the platelet glycoprotein Ⅰ b (GP Ⅰb) essential for the von Willebrand factor binding by clustered charged-to-alanine scanning mutagenesis [J]. J Biol Chem, 2004 ,279(16): 16285 - 16294.
8Margaglinne M, D'Andrea G, Grandone E, et al. Compound heterozygosity (554-589 del, C515-T transition) in the platelet glycoprotein Ⅰ bα gene in a patient with a severe bleeding tendency[ J]. Thromb Haemost, 1999,81(4):486-492.
9Antonucci JV, Martin ES, Hulick PJ, et al. Bernard-Soulier syndrome: common ancestry in two African American families with the GP Ⅰ bα Leu129Pro mutation[J]. Am J Hematol, 2000,65(2): 141 - 148.
10Matsubara Y, Murata M, Moriki T, et al. A novel polymorphism, 70 Leu/Phe, disrupts a consensus Leu residue within the leucine-rich repeat sequence of platelet glycoprotein Ⅰ bα[J]. Thromb Hoemost, 2002,87(5) :867 - 872.
3Doweik L, Maca T, Schillinger M, et al. Fibrinogen predict mortality in high risk patients with peripheral artery disease[J]. Eur J Vasc Endovasc Surg,2003,26(4):381-386.
4Rudofsky G,StrubeI G, Michler E, et al. Influence of fibrinogen and hematocrit on the early outcome of angioplasty in patients with PAOD[J]. J Endovasc Ther,2004,11(2) :125-131.
